Body fat indices and survival in immunotherapy-treated patients with cancer
- PMID: 32286680
- PMCID: PMC7422929
- DOI: 10.1002/cncr.32889
Body fat indices and survival in immunotherapy-treated patients with cancer
Conflict of interest statement
CONFLICT OF INTEREST DISCLOSURES
The authors made no disclosures.
Comment in
-
Reply to Body fat indices and survival in immunotherapy-treated patients with cancer.Cancer. 2020 Jul 1;126(13):3157-3159. doi: 10.1002/cncr.32886. Epub 2020 Apr 14. Cancer. 2020. PMID: 32286681 No abstract available.
Comment on
-
Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials.Cancer. 2020 Feb 1;126(3):575-582. doi: 10.1002/cncr.32576. Epub 2019 Oct 24. Cancer. 2020. PMID: 31648379
References
-
- Martini DJ, Kline MR, Liu Y, et al. Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials. Cancer. 2020;126:575–582. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical